Optomed PLC

Optomed PLC

OPTOMED · HE · Healthcare / Health Information Services

1.66EUR-0.00 (-0.24%)

Price History

Full chart

Market Stats

Previous Close1.66
Open1.66
Day Range1.65 – 1.71
52-Week Range1.33 – 4.33
Volume37.49K
Market Cap31.35M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.28
Dividend Yield0.00%
Beta1.57
50-Day Avg1.62
200-Day Avg2.25

About

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists' work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed Radiology Information System, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Cephalometry, a powerful, flexible, and easy-to-use Windows software for orthodontics, oral and maxillofacial surgery; and Pathology PACS, which allows digital pathology images to be reviewed and shared. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Juho Himberg
  • Employees110
  • HeadquartersYrttipellontie 1, Oulu, Finland, 90230, Finland
  • Websitehttps://www.optomed.com

Leadership

  • Mr. Juho HimbergChief Executive Officer · b. 1970
  • Mr. Sakari KnuuttiCFO, Chief Legal Officer & Secretary of the Board · b. 1984
  • Mr. Seppo Henrik KopsalaFounder · b. 1978

Financials

Income Statement

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.61M6.90M14.46M14.98M13.01M14.85M14.66M15.10M15.04M17.10M
Growth (%)-+4.39%+109.64%+3.55%-13.13%+14.13%-1.28%+3.00%-0.40%+13.67%
Cost of Revenue2.99M3.12M4.95M5.29M4.21M5.10M5.45M4.86M5.37M17.47M
Gross Profit3.62M3.78M9.51M9.69M8.80M9.75M9.21M10.24M9.67M-370.00K
Gross Margin54.76%54.81%65.75%64.71%67.62%65.64%62.84%67.83%64.27%-2.16%
Operating Expense6.23M6.61M10.17M11.90M11.54M14.12M13.88M14.22M15.62M5.68M
Operating Income-2.61M-2.83M-665.00K-2.21M-2.75M-4.37M-4.67M-3.97M-5.96M-6.05M
Operating Margin-39.51%-40.98%-4.60%-14.76%-21.10%-29.44%-31.86%-26.32%-39.61%-35.36%
EBITDA-1.91M-1.65M376.00K-1.17M-281.00K-2.97M-4.23M-1.30M-2.24M-3.53M
EBITDA Margin-28.82%-23.92%2.60%-7.84%-2.16%-20.01%-28.85%-8.62%-14.90%-20.65%
Net Income-2.76M-2.89M-1.27M-2.88M-3.18M-4.25M-5.47M-4.44M-5.45M-6.64M
Net Income Margin-41.73%-41.85%-8.77%-19.20%-24.42%-28.61%-37.33%-29.41%-36.24%-38.84%
R&D532.00K227.00K1.07M356.00K276.00K412.00K361.00K2.95M297.00K1.64M
R&D as % of Total Revenue8.05%3.29%7.41%2.38%2.12%2.77%2.46%19.51%1.97%9.56%
Interest Expense89.00K197.00K594.00K365.00K171.00K165.00K268.00K288.00K776.00K1.26M
Interest Expense % of Total Revenue1.35%2.86%4.11%2.44%1.31%1.11%1.83%1.91%5.16%7.35%

Balance Sheet

Currency: EUR2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.52M10.03M9.92M21.15M39.61M31.07M29.00M31.30M29.08M31.78M31.97M
Total Liabilities5.77M6.50M8.76M15.59M16.97M11.00M11.95M10.96M8.72M8.14M7.96M
Total Equity3.75M3.52M1.16M5.55M22.64M20.07M17.05M20.34M20.36M23.64M24.02M
Cash2.82M1.62M1.03M2.00M18.87M10.61M6.80M8.52M7.12M10.47M9.91M
Total Debt3.73M3.79M6.15M11.33M11.04M7.72M8.23M6.74M4.86M3.81M2.71M
Net Debt911.00K2.17M5.12M9.33M-7.83M-2.88M1.43M-1.78M-2.26M-6.66M-7.20M

Cash Flow

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-810.00K-766.00K-76.00K161.00K-2.80M-2.94M-2.37M-615.00K-1.60M-2.48M
Investing Cash Flow-1.89M-1.91M-8.77M-1.43M-1.82M-2.57M-3.03M-2.41M-2.12M-2.36M
Financing Cash Flow1.50M2.14M9.81M18.12M-3.70M1.64M7.00M1.61M7.08M4.19M
Capital Expenditure1.91M1.93M1.70M1.44M1.82M2.57M3.03M2.41M2.12M2.36M
Free Cash Flow-2.72M-2.69M-1.77M-1.27M-4.62M-5.51M-5.40M-3.03M-3.71M-4.84M
FCF to OCF336.17%351.83%2335.53%-791.30%165.01%187.55%227.81%492.20%232.71%194.96%

Earnings

Report DateFeb 28, 2020May 29, 2020Aug 27, 2020Nov 25, 2020Feb 18, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 17, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 17, 2023May 5, 2023Aug 4, 2023Nov 3, 2023Feb 15, 2024May 7, 2024Aug 8, 2024Nov 7, 2024Feb 13, 2025May 6, 2025Aug 7, 2025Nov 6, 2025Feb 10, 2026May 6, 2026Aug 14, 2026Nov 6, 2026
EPS Estimate-0.20-0.07-0.07-0.06-0.05-0.07-0.07-0.07-0.10-0.11-0.10-0.06-0.09-0.08-0.06-0.07-0.04-0.06-0.04-0.09-0.01-0.07-0.07-0.07-0.05-0.07-0.05-0.03
EPS Actual-0.01-0.12-0.08-0.02-0.05-0.05-0.06-0.06-0.14-0.10-0.10-0.10-0.10-0.08-0.08-0.01-0.09-0.06-0.10-0.09-0.04-0.08-0.08-0.08-0.10-0.05-0.05-
Surprise95.00%-71.43%-14.29%66.67%0.00%28.57%14.29%14.29%-40.00%9.09%0.00%-66.67%-11.11%0.00%-33.33%85.71%-125.00%0.00%-150.00%0.00%-300.00%-14.29%-14.29%-14.29%-100.00%28.57%0.00%-
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap31.35M
Enterprise Value29.03M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.94
Price / Book1.54
EPS-0.28
Book Value1.01
Revenue (TTM)16.10M
Gross Profit (TTM)10.49M
EBITDA-4.90M
Profit Margin-33.86%
Operating Margin-32.29%
Return on Equity-25.43%
Return on Assets-12.47%
Shares Outstanding21.47M
Shares Float20.84M
Beta1.57
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%